ArticleCureus2023

The Add-On Effect of Fluorouracil, Epirubicin, and Cyclophosphamide Regimens for Neoadjuvant Chemotherapy in Human Epidermal Receptor 2 (HER2)-Positive Breast Cancer: A Single-Center Retrospective Study.

Ryusei Yoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.